Viral epidemiology and SARS-CoV-2 co-infections with other respiratory viruses during the first COVID-19 wave in Paris, France.


Journal

Influenza and other respiratory viruses
ISSN: 1750-2659
Titre abrégé: Influenza Other Respir Viruses
Pays: England
ID NLM: 101304007

Informations de publication

Date de publication:
07 2021
Historique:
received: 26 02 2021
accepted: 27 02 2021
pubmed: 6 4 2021
medline: 22 6 2021
entrez: 5 4 2021
Statut: ppublish

Résumé

Our work assessed the prevalence of co-infections in patients with SARS-CoV-2. All patients hospitalized in a Parisian hospital during the first wave of COVID-19 were tested by multiplex PCR if they presented ILI symptoms. A total of 806 patients (21%) were positive for SARS-CoV-2, 755 (20%) were positive for other respiratory viruses. Among the SARS-CoV-2-positive patients, 49 (6%) had viral co-infections. They presented similar age, symptoms, except for fever (P = .013) and headaches (P = .048), than single SARS-CoV-2 infections. SARS-CoV-2-infected patients presenting viral co-infections had similar clinical characteristics and prognosis than patients solely infected with SARS-CoV-2.

Identifiants

pubmed: 33817971
doi: 10.1111/irv.12853
pmc: PMC8189235
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

425-428

Informations de copyright

© 2021 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.

Références

N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
Clin Microbiol Infect. 2021 Apr;27(4):631.e1-631.e6
pubmed: 32540470
Clin Infect Dis. 2021 Jun 15;72(12):e978-e992
pubmed: 33216851
J Infect. 2020 Aug;81(2):266-275
pubmed: 32473235
Influenza Other Respir Viruses. 2021 Jul;15(4):425-428
pubmed: 33817971
JAMA. 2020 May 26;323(20):2085-2086
pubmed: 32293646
J Clin Virol. 2020 Sep;130:104573
pubmed: 32769025
J Med Virol. 2020 Oct;92(10):1699-1700
pubmed: 32352574
PLoS One. 2020 Dec 3;15(12):e0243261
pubmed: 33270790
J Microbiol Immunol Infect. 2020 Aug;53(4):505-512
pubmed: 32482366
PLoS One. 2017 Jul 14;12(7):e0180888
pubmed: 28708843
J Clin Virol. 2020 Aug;129:104520
pubmed: 32652476
J Clin Microbiol. 2018 May 25;56(6):
pubmed: 29593057
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32341142
BMJ. 2020 May 22;369:m1985
pubmed: 32444460

Auteurs

Quentin Le Hingrat (Q)

INSERM, IAME, Université de Paris, Paris, France.
AP-HP Nord, Virology Department, Bichat-Claude Bernard University Hospital, Paris, France.

Donia Bouzid (D)

INSERM, IAME, Université de Paris, Paris, France.
AP-HP Nord, Emergency Department, Bichat-Claude Bernard University Hospital, Paris, France.

Christophe Choquet (C)

AP-HP Nord, Emergency Department, Bichat-Claude Bernard University Hospital, Paris, France.

Odile Laurent (O)

AP-HP Nord, Emergency Department, Bichat-Claude Bernard University Hospital, Paris, France.

François-Xavier Lescure (FX)

INSERM, IAME, Université de Paris, Paris, France.
AP-HP Nord, Infectious Diseases Department, Bichat-Claude Bernard University Hospital, Paris, France.

Jean-François Timsit (JF)

INSERM, IAME, Université de Paris, Paris, France.
AP-HP Nord, Medical and Infectious Diseases Intensive Care Unit, Bichat-Claude Bernard University Hospital, Paris, France.

Nadhira Houhou-Fidouh (N)

AP-HP Nord, Virology Department, Bichat-Claude Bernard University Hospital, Paris, France.

Enrique Casalino (E)

INSERM, IAME, Université de Paris, Paris, France.
AP-HP Nord, Emergency Department, Bichat-Claude Bernard University Hospital, Paris, France.

Jean-Christophe Lucet (JC)

INSERM, IAME, Université de Paris, Paris, France.
AP-HP Nord, Infection Control Unit, Bichat-Claude Bernard University Hospital, Paris, France.

Diane Descamps (D)

INSERM, IAME, Université de Paris, Paris, France.
AP-HP Nord, Virology Department, Bichat-Claude Bernard University Hospital, Paris, France.

Benoit Visseaux (B)

INSERM, IAME, Université de Paris, Paris, France.
AP-HP Nord, Virology Department, Bichat-Claude Bernard University Hospital, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH